Literature DB >> 28239657

Tissue-resident macrophages can contain replication-competent virus in antiretroviral-naive, SIV-infected Asian macaques.

Sarah R DiNapoli1, Alexandra M Ortiz1, Fan Wu2, Kenta Matsuda2, Homer L Twigg3, Vanessa M Hirsch2, Kenneth Knox4, Jason M Brenchley1.   

Abstract

SIV DNA can be detected in lymphoid tissue-resident macrophages of chronically SIV-infected Asian macaques. These macrophages also contain evidence of recently phagocytosed SIV-infected CD4+ T cells. Here, we examine whether these macrophages contain replication-competent virus, whether viral DNA can be detected in tissue-resident macrophages from antiretroviral (ARV) therapy-treated animals and humans, and how the viral sequences amplified from macrophages and contemporaneous CD4+ T cells compare. In ARV-naive animals, we find that lymphoid tissue-resident macrophages contain replication-competent virus if they also contain viral DNA in ARV-naive Asian macaques. The genetic sequence of the virus within these macrophages is similar to those within CD4+ T cells from the same anatomic sites. In ARV-treated animals, we find that viral DNA can be amplified from lymphoid tissue-resident macrophages of SIV-infected Asian macaques that were treated with ARVs for at least 5 months, but we could not detect replication-competent virus from macrophages of animals treated with ARVs. Finally, we could not detect viral DNA in alveolar macrophages from HIV-infected individuals who received ARVs for 3 years and had undetectable viral loads. These data demonstrate that macrophages can contain replication-competent virus, but may not represent a significant reservoir for HIV in vivo.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28239657      PMCID: PMC5313072          DOI: 10.1172/jci.insight.91214

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  71 in total

1.  HIV insertions within and proximal to host cell genes are a common finding in tissues containing high levels of HIV DNA and macrophage-associated p24 antigen expression.

Authors:  K D Mack; X Jin; S Yu; R Wei; L Kapp; C Green; B Herndier; N W Abbey; A Elbaggari; Y Liu; M S McGrath
Journal:  J Acquir Immune Defic Syndr       Date:  2003-07-01       Impact factor: 3.731

Review 2.  Effect of HIV clade differences on the onset and severity of HIV-associated neurocognitive disorders.

Authors:  William Tyor; Cari Fritz-French; Avindra Nath
Journal:  J Neurovirol       Date:  2013-10-16       Impact factor: 2.643

3.  Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption.

Authors:  Meghan K Rothenberger; Brandon F Keele; Stephen W Wietgrefe; Courtney V Fletcher; Gregory J Beilman; Jeffrey G Chipman; Alexander Khoruts; Jacob D Estes; Jodi Anderson; Samuel P Callisto; Thomas E Schmidt; Ann Thorkelson; Cavan Reilly; Katherine Perkey; Thomas G Reimann; Netanya S Utay; Krystelle Nganou Makamdop; Mario Stevenson; Daniel C Douek; Ashley T Haase; Timothy W Schacker
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-23       Impact factor: 11.205

4.  The role of mononuclear phagocytes in HTLV-III/LAV infection.

Authors:  S Gartner; P Markovits; D M Markovitz; M H Kaplan; R C Gallo; M Popovic
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

Review 5.  Macrophages in Progressive Human Immunodeficiency Virus/Simian Immunodeficiency Virus Infections.

Authors:  Sarah R DiNapoli; Vanessa M Hirsch; Jason M Brenchley
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

6.  Bioinformatic analysis of neurotropic HIV envelope sequences identifies polymorphisms in the gp120 bridging sheet that increase macrophage-tropism through enhanced interactions with CCR5.

Authors:  Megan E Mefford; Kevin Kunstman; Steven M Wolinsky; Dana Gabuzda
Journal:  Virology       Date:  2015-03-20       Impact factor: 3.616

7.  Identification and biologic characterization of an acutely lethal variant of simian immunodeficiency virus from sooty mangabeys (SIV/SMM).

Authors:  P N Fultz; H M McClure; D C Anderson; W M Switzer
Journal:  AIDS Res Hum Retroviruses       Date:  1989-08       Impact factor: 2.205

8.  Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection.

Authors:  N R Klatt; J D Estes; X Sun; A M Ortiz; J S Barber; L D Harris; B Cervasi; L K Yokomizo; L Pan; C L Vinton; B Tabb; L A Canary; Q Dang; V M Hirsch; G Alter; Y Belkaid; J D Lifson; G Silvestri; J D Milner; M Paiardini; E K Haddad; J M Brenchley
Journal:  Mucosal Immunol       Date:  2012-05-30       Impact factor: 7.313

9.  Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS.

Authors:  K C Williams; S Corey; S V Westmoreland; D Pauley; H Knight; C deBakker; X Alvarez; A A Lackner
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

10.  Macrophage infection via selective capture of HIV-1-infected CD4+ T cells.

Authors:  Amy E Baxter; Rebecca A Russell; Christopher J A Duncan; Michael D Moore; Christian B Willberg; Jose L Pablos; Andrés Finzi; Daniel E Kaufmann; Christina Ochsenbauer; John C Kappes; Fedde Groot; Quentin J Sattentau
Journal:  Cell Host Microbe       Date:  2014-11-20       Impact factor: 21.023

View more
  40 in total

1.  No recovery of replication-competent HIV-1 from human liver macrophages.

Authors:  Abraham J Kandathil; Sho Sugawara; Ashish Goyal; Christine M Durand; Jeffrey Quinn; Jaiprasath Sachithanandham; Andrew M Cameron; Justin R Bailey; Alan S Perelson; Ashwin Balagopal
Journal:  J Clin Invest       Date:  2018-09-10       Impact factor: 14.808

Review 2.  Advances toward Curing HIV-1 Infection in Tissue Reservoirs.

Authors:  Lisa J Henderson; Lauren B Reoma; Joseph A Kovacs; Avindra Nath
Journal:  J Virol       Date:  2020-01-17       Impact factor: 5.103

3.  Infrequent HIV Infection of Circulating Monocytes during Antiretroviral Therapy.

Authors:  Marta Massanella; Wendy Bakeman; Pasiri Sithinamsuwan; James L K Fletcher; Nitiya Chomchey; Somporn Tipsuk; Thep Chalermchai; Jean-Pierre Routy; Jintanat Ananworanich; Victor G Valcour; Nicolas Chomont
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

Review 4.  HIV Latency in Myeloid Cells: Challenges for a Cure.

Authors:  Alisha Chitrakar; Marta Sanz; Sanjay B Maggirwar; Natalia Soriano-Sarabia
Journal:  Pathogens       Date:  2022-05-24

Review 5.  Differentiating Immune Cell Targets in Gut-Associated Lymphoid Tissue for HIV Cure.

Authors:  Shahzada Khan; Sushama Telwatte; Martin Trapecar; Steven Yukl; Shomyseh Sanjabi
Journal:  AIDS Res Hum Retroviruses       Date:  2017-11       Impact factor: 2.205

6.  T Cell-Macrophage Fusion Triggers Multinucleated Giant Cell Formation for HIV-1 Spreading.

Authors:  Lucie Bracq; Maorong Xie; Marie Lambelé; Lan-Trang Vu; Julie Matz; Alain Schmitt; Jérôme Delon; Paul Zhou; Clotilde Randriamampita; Jérôme Bouchet; Serge Benichou
Journal:  J Virol       Date:  2017-11-30       Impact factor: 5.103

Review 7.  Macrophages at CNS interfaces: ontogeny and function in health and disease.

Authors:  Katrin Kierdorf; Takahiro Masuda; Marta Joana Costa Jordão; Marco Prinz
Journal:  Nat Rev Neurosci       Date:  2019-07-29       Impact factor: 34.870

Review 8.  Chronic obstructive pulmonary disease in HIV.

Authors:  Katerina Byanova; Ken M Kunisaki; Joshua Vasquez; Laurence Huang
Journal:  Expert Rev Respir Med       Date:  2020-11-23       Impact factor: 3.772

9.  Development of a Novel In Vitro Primary Human Monocyte-Derived Macrophage Model To Study Reactivation of HIV-1 Transcription.

Authors:  Anna C Hearps; Anthony Jaworowski; Michelle E Wong; Chad J Johnson
Journal:  J Virol       Date:  2021-09-09       Impact factor: 5.103

10.  Immune Responses and Viral Persistence in Simian/Human Immunodeficiency Virus SHIV.C.CH848-Infected Rhesus Macaques.

Authors:  Widade Ziani; Anya Bauer; Hong Lu; Xiaolei Wang; Xueling Wu; Katharine J Bar; Hui Li; Dongfang Liu; George M Shaw; Ronald S Veazey; Huanbin Xu
Journal:  J Virol       Date:  2021-04-12       Impact factor: 6.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.